DRG Epidemiology’s coverage of soft tissue sarcoma comprises epidemiological estimates of key patient populations in 45 countries worldwide. We report both the incidence and prevalence of soft tissue sarcoma for each country, as well as annualized case counts projected to the national population.

In addition to forecasting incident and prevalent patient populations, we estimate the number of drug-treatment opportunities in specific lines of therapy.

DRG Epidemiology’s soft tissue sarcoma forecast will answer the following questions:

  • In developing countries, what impact will economic growth and development have on the number of people diagnosed with soft tissue sarcoma each year?
  • How will demographic trends, such as population aging and improving life expectancy, affect the epidemiology of soft tissue sarcoma over the forecast period?

All forecast data are available on the DRG Insights Platform in tabular format, with options to download to MS Excel. All populations are accompanied by a comprehensive description of the methods and data sources used, with hyperlinks to external sources. A summary evidence table generated as part of our systematic review of the epidemiological literature is provided for full transparency into research and methods. In addition, we provide a graph depicting the patient flow between or within different disease states for the major mature pharmaceutical markets. These patient-flow diagrams are provided at the regional level but may be requested for any specific country or forecast year.

Note: Coverage may vary by country

Table of contents

  • Epidemiology Dashboard
    • Introduction
      • Soft Tissue Sarcoma Epidemiology Dashboard

Author(s): Narendra Parihar

Narendra is an associate epidemiologist within the epidemiology team at Decision Resources Group. Narendra specializes in developing epidemiological forecasts for multiple indications within the DRG syndicated portfolio. His qualifications include an MPH with specialization in Health Policy, Economics and Finance from the Tata Institute of Social Sciences, Mumbai, and a Bachelor’s degree in Dentistry from the Rajasthan University of Health Sciences.


Related Reports

Soft Tissue Sarcoma | Epidemiology | Extrapolated Worldwide Coverage

DRG’s extended worldwide coverage is the first and only evidence-based data set of epidemiological forecasts for key soft tissue sarcoma patien...

View Details

Soft Tissue Sarcoma | Epidemiology | Americas

DRG Epidemiology's coverage of soft tissue sarcoma comprises epidemiological estimates of key patient populations across the Americas (Argentina, Canada, Chile, Colombia, and Peru). We report...

View Details

Soft Tissue Sarcoma | Epidemiology | Europe

DRG Epidemiology's coverage of soft tissue sarcoma comprises epidemiological estimates of key patient populations across Europe (Austria, Belgium, Czech Republic, Denmark, Finland, Greece, Ne...

View Details

Soft Tissue Sarcoma | Epidemiology | Emerging Markets

DRG Epidemiology's coverage of soft tissue sarcoma comprises epidemiological estimates of key patient populations across the Emerging Markets (Brazil, China, India, Mexico, Russia, South...

View Details